- US12404300utility2025Mitochondria-targeting Peptides0 cites
- US12337023utility2025Methods and Compositions for the Prevention and Treatment of Disease0 cites
- US12297502utility2025Methods and Compositions for Detecting and Diagnosing Diseases and Conditions0 cites
- US12268724utility2025Methods and Compositions for the Prevention or Treatment of Barth Syndrome0 cites
- US12252553utility2025Crystalline Salt Forms0 cites
- US12252554utility2025Analogs That Target Mitochondrial Diseases0 cites
- US12110345utility2024Crystalline Salt Forms of Boc-d-arg-dmt-lys-(boc)-phe-nh 20 cites
- US12065511utility2024Aromatic-cationic Peptides and Uses of Same0 cites
- US12037414utility2024Processes for Preparing Pharmaceutically Relevant Peptides0 cites
- US12018094utility2024Crystalline Dipeptides Useful in the Synthesis of Elamipretide0 cites
- US11998585utility2024Methods and Compositions for Increasing the Dose of a Chemotherapeutic Agent0 cites
- US11944662utility2024Methods and Compositions for Preventing or Treating Ophthalmic Conditions0 cites
- US11931397utility2024Methods and Compositions for the Treatment of Sengers Syndrome0 cites
- US11795196utility2023Mitochondria-targeting Peptides0 cites
- US11771734utility2023Methods and Compositions for the Prevention or Treatment of Barth Syndrome0 cites
- US11773136utility2023Crystalline Salt Forms of Boc-d-arg-dmt-lys-(boc)-phe-nh 20 cites
- US11672841utility2023Methods for Treating Heart Disease in a Subject with Friedreich's Ataxia by an Aromatic-cationic Peptide0 cites
Page 1 of 2Next →